TG Therapeutics | TGTX - Ebitda

Stock Price
29.66
Daily Change
-0.85 -2.79%
Monthly
-3.32%
Yearly
1.09%
Q1 Forecast
28.61

TG Therapeutics reported $37.7M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Amgen USD 5.14B 775M Dec/2025
Ardelyx USD 5.57M 17.44M Sep/2025
Arrowhead Research USD 64.2M 223.53M Sep/2025
Bayer EUR 1.51B 1.28B Sep/2025
Biogen USD 573.2M 253.7M Dec/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Curis USD -12.3M 231K Sep/2023
Gilead Sciences USD 4.03B 628M Sep/2025
Infinity Pharmaceuticals USD -10.01M 1.39M Jun/2023
J&J USD 9.52B 389M Sep/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Novartis USD 5.88B 290M Sep/2025
Novavax USD -117.12M 55.66M Sep/2024
PTC Therapeutics USD 20.63M 53.74M Sep/2025
Puma Biotechnology USD 729K 11.36M Jun/2024
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
TG Therapeutics USD 37.7M 25.41M Jun/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025